| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 334 | 2025 | 8724 | 13.300 |
Why?
|
| Amyloid beta-Protein Precursor | 122 | 2025 | 1116 | 7.640 |
Why?
|
| Amyloid beta-Peptides | 164 | 2024 | 3892 | 7.450 |
Why?
|
| Amyloid Precursor Protein Secretases | 58 | 2024 | 617 | 7.050 |
Why?
|
| Microglia | 24 | 2024 | 1371 | 2.760 |
Why?
|
| Apolipoproteins E | 40 | 2024 | 1459 | 2.290 |
Why?
|
| Presenilin-1 | 48 | 2024 | 665 | 2.130 |
Why?
|
| Genetic Predisposition to Disease | 58 | 2024 | 18076 | 2.000 |
Why?
|
| Aspartic Acid Endopeptidases | 20 | 2024 | 308 | 1.970 |
Why?
|
| Membrane Glycoproteins | 16 | 2022 | 3692 | 1.780 |
Why?
|
| Amyloid | 23 | 2024 | 848 | 1.760 |
Why?
|
| Receptors, Immunologic | 12 | 2022 | 1416 | 1.740 |
Why?
|
| Plaque, Amyloid | 23 | 2024 | 770 | 1.730 |
Why?
|
| Peptide Fragments | 49 | 2024 | 5126 | 1.700 |
Why?
|
| Genetic Linkage | 49 | 2008 | 2342 | 1.540 |
Why?
|
| Membrane Proteins | 48 | 2023 | 7850 | 1.520 |
Why?
|
| Caspases | 12 | 2008 | 881 | 1.500 |
Why?
|
| tau Proteins | 31 | 2024 | 2110 | 1.450 |
Why?
|
| Cromolyn Sodium | 3 | 2021 | 76 | 1.440 |
Why?
|
| Brain | 98 | 2024 | 27177 | 1.440 |
Why?
|
| Mice, Transgenic | 60 | 2024 | 9540 | 1.430 |
Why?
|
| Isoflurane | 12 | 2012 | 384 | 1.430 |
Why?
|
| Neurons | 54 | 2025 | 9521 | 1.340 |
Why?
|
| Neurogenesis | 8 | 2023 | 864 | 1.240 |
Why?
|
| Anesthetics, Inhalation | 13 | 2021 | 573 | 1.210 |
Why?
|
| Carrier Proteins | 17 | 2022 | 4910 | 1.180 |
Why?
|
| Nerve Tissue Proteins | 29 | 2024 | 4399 | 1.170 |
Why?
|
| Genome-Wide Association Study | 32 | 2024 | 12803 | 1.140 |
Why?
|
| Zinc | 20 | 2012 | 675 | 1.110 |
Why?
|
| Chromosomes, Human, Pair 21 | 26 | 2005 | 228 | 1.100 |
Why?
|
| Presenilin-2 | 22 | 2019 | 100 | 1.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 7 | 2007 | 275 | 0.990 |
Why?
|
| SOXD Transcription Factors | 2 | 2017 | 44 | 0.980 |
Why?
|
| Animals | 215 | 2024 | 168800 | 0.980 |
Why?
|
| Hippocampus | 20 | 2023 | 3773 | 0.960 |
Why?
|
| Mice | 130 | 2024 | 81839 | 0.940 |
Why?
|
| Adaptor Proteins, Signal Transducing | 20 | 2022 | 2898 | 0.930 |
Why?
|
| Copper | 23 | 2010 | 365 | 0.930 |
Why?
|
| Amyloidosis | 12 | 2024 | 883 | 0.920 |
Why?
|
| Phenethylamines | 3 | 2021 | 95 | 0.900 |
Why?
|
| Cell Cycle Proteins | 12 | 2022 | 3436 | 0.880 |
Why?
|
| Disease Models, Animal | 50 | 2024 | 18321 | 0.870 |
Why?
|
| Databases, Genetic | 9 | 2020 | 1756 | 0.870 |
Why?
|
| Drosophila Proteins | 7 | 2019 | 1704 | 0.870 |
Why?
|
| Cognition | 18 | 2024 | 7050 | 0.840 |
Why?
|
| Humans | 457 | 2025 | 766117 | 0.840 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2024 | 16040 | 0.820 |
Why?
|
| Mutation | 56 | 2024 | 30209 | 0.810 |
Why?
|
| Medicine, Ayurvedic | 3 | 2017 | 37 | 0.810 |
Why?
|
| Curcumin | 4 | 2023 | 97 | 0.810 |
Why?
|
| Pyridazines | 3 | 2021 | 199 | 0.800 |
Why?
|
| Apolipoprotein E4 | 21 | 2023 | 707 | 0.800 |
Why?
|
| Gene Frequency | 17 | 2023 | 3623 | 0.800 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2022 | 60 | 0.780 |
Why?
|
| Neuroprotective Agents | 5 | 2021 | 959 | 0.780 |
Why?
|
| ADAM Proteins | 3 | 2013 | 243 | 0.760 |
Why?
|
| Presenilins | 4 | 2011 | 51 | 0.740 |
Why?
|
| Neuropeptides | 3 | 2022 | 950 | 0.720 |
Why?
|
| Endoplasmic Reticulum | 6 | 2025 | 1132 | 0.720 |
Why?
|
| RNA Interference | 9 | 2017 | 2828 | 0.720 |
Why?
|
| Insulysin | 6 | 2007 | 49 | 0.700 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2024 | 2469 | 0.690 |
Why?
|
| Neurofibrillary Tangles | 11 | 2021 | 457 | 0.690 |
Why?
|
| Mast Cells | 2 | 2024 | 1404 | 0.690 |
Why?
|
| Nuclear Proteins | 9 | 2022 | 5791 | 0.690 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2015 | 1962 | 0.680 |
Why?
|
| Cricetinae | 28 | 2019 | 2413 | 0.660 |
Why?
|
| alpha-Macroglobulins | 8 | 2007 | 60 | 0.650 |
Why?
|
| Genetic Association Studies | 7 | 2020 | 2744 | 0.640 |
Why?
|
| Neural Stem Cells | 11 | 2022 | 897 | 0.640 |
Why?
|
| CHO Cells | 22 | 2019 | 1373 | 0.630 |
Why?
|
| Family | 12 | 2020 | 3208 | 0.630 |
Why?
|
| Apoptosis | 19 | 2015 | 9508 | 0.630 |
Why?
|
| Drosophila | 7 | 2019 | 1506 | 0.620 |
Why?
|
| Gene Silencing | 6 | 2017 | 1504 | 0.620 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 4 | 2020 | 299 | 0.610 |
Why?
|
| Age of Onset | 23 | 2024 | 3344 | 0.610 |
Why?
|
| Genetic Loci | 7 | 2024 | 2630 | 0.610 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 572 | 0.590 |
Why?
|
| Neuroimmunomodulation | 4 | 2024 | 186 | 0.590 |
Why?
|
| Caspase 3 | 12 | 2011 | 731 | 0.560 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2020 | 1482 | 0.560 |
Why?
|
| Axons | 5 | 2022 | 1677 | 0.550 |
Why?
|
| Nervous System Diseases | 5 | 2023 | 1657 | 0.550 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 607 | 0.550 |
Why?
|
| Ibuprofen | 2 | 2018 | 228 | 0.550 |
Why?
|
| Chromosome Mapping | 43 | 2009 | 4617 | 0.550 |
Why?
|
| Polymorphism, Genetic | 30 | 2022 | 4249 | 0.550 |
Why?
|
| Genotype | 35 | 2022 | 13028 | 0.550 |
Why?
|
| Mutation, Missense | 5 | 2014 | 2590 | 0.530 |
Why?
|
| Mind-Body Therapies | 2 | 2017 | 294 | 0.530 |
Why?
|
| Cricetulus | 16 | 2019 | 807 | 0.530 |
Why?
|
| Endopeptidases | 9 | 2020 | 760 | 0.520 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2016 | 17 | 0.520 |
Why?
|
| Blotting, Western | 25 | 2017 | 5020 | 0.520 |
Why?
|
| Mitochondria | 7 | 2025 | 3672 | 0.510 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2019 | 176 | 0.500 |
Why?
|
| Spheroids, Cellular | 3 | 2024 | 329 | 0.500 |
Why?
|
| Enzyme Inhibitors | 10 | 2020 | 3722 | 0.490 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 156 | 0.490 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2022 | 2795 | 0.480 |
Why?
|
| Spirituality | 2 | 2017 | 430 | 0.480 |
Why?
|
| Phospholipase D | 1 | 2015 | 71 | 0.470 |
Why?
|
| Metals | 8 | 2008 | 709 | 0.470 |
Why?
|
| Flow Cytometry | 4 | 2024 | 5881 | 0.470 |
Why?
|
| Cognition Disorders | 15 | 2021 | 3966 | 0.470 |
Why?
|
| Pedigree | 35 | 2015 | 4535 | 0.470 |
Why?
|
| Dementia | 10 | 2024 | 2741 | 0.460 |
Why?
|
| Cells, Cultured | 35 | 2024 | 18967 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2024 | 2879 | 0.450 |
Why?
|
| Brain Chemistry | 9 | 2012 | 951 | 0.440 |
Why?
|
| Anti-Infective Agents | 2 | 2018 | 987 | 0.440 |
Why?
|
| Down Syndrome | 12 | 2024 | 915 | 0.440 |
Why?
|
| SOX Transcription Factors | 1 | 2013 | 7 | 0.440 |
Why?
|
| Aging | 17 | 2024 | 8723 | 0.430 |
Why?
|
| Genetic Variation | 10 | 2020 | 6612 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 5 | 2022 | 1088 | 0.420 |
Why?
|
| Genes | 11 | 2000 | 1824 | 0.420 |
Why?
|
| Nerve Degeneration | 5 | 2018 | 748 | 0.420 |
Why?
|
| Clusterin | 2 | 2011 | 72 | 0.420 |
Why?
|
| Transfection | 24 | 2012 | 5739 | 0.410 |
Why?
|
| Protein Precursors | 14 | 1996 | 1133 | 0.400 |
Why?
|
| Clioquinol | 8 | 2010 | 23 | 0.390 |
Why?
|
| Phagocytosis | 5 | 2022 | 1518 | 0.390 |
Why?
|
| Cell Culture Techniques | 7 | 2020 | 1651 | 0.390 |
Why?
|
| Linkage Disequilibrium | 12 | 2017 | 1996 | 0.390 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2024 | 146 | 0.380 |
Why?
|
| Enzyme Activation | 13 | 2012 | 3584 | 0.380 |
Why?
|
| Alleles | 25 | 2022 | 6892 | 0.380 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 14 | 2014 | 3801 | 0.380 |
Why?
|
| Male | 142 | 2024 | 363935 | 0.380 |
Why?
|
| Cell Line, Tumor | 28 | 2024 | 17071 | 0.370 |
Why?
|
| Neuroglia | 3 | 2023 | 963 | 0.370 |
Why?
|
| Drosophila melanogaster | 3 | 2020 | 1725 | 0.360 |
Why?
|
| Metalloproteins | 3 | 2008 | 98 | 0.360 |
Why?
|
| Down-Regulation | 3 | 2023 | 2927 | 0.360 |
Why?
|
| Gene Expression | 13 | 2021 | 7582 | 0.360 |
Why?
|
| Cell Count | 2 | 2010 | 1825 | 0.360 |
Why?
|
| Taurochenodeoxycholic Acid | 2 | 2020 | 35 | 0.350 |
Why?
|
| Molecular Chaperones | 2 | 2024 | 760 | 0.350 |
Why?
|
| Aged | 95 | 2024 | 171219 | 0.350 |
Why?
|
| Calcium Channels | 6 | 2011 | 622 | 0.350 |
Why?
|
| Phenylbutyrates | 2 | 2020 | 72 | 0.350 |
Why?
|
| Immunity, Innate | 7 | 2021 | 3079 | 0.340 |
Why?
|
| Astrocytes | 7 | 2024 | 1353 | 0.340 |
Why?
|
| RNA, Messenger | 25 | 2017 | 12775 | 0.330 |
Why?
|
| Molecular Imaging | 4 | 2024 | 822 | 0.330 |
Why?
|
| Protein Transport | 8 | 2023 | 1939 | 0.330 |
Why?
|
| Genetic Markers | 25 | 2009 | 2603 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4649 | 0.330 |
Why?
|
| Chelating Agents | 10 | 2007 | 380 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 25 | 2024 | 22341 | 0.320 |
Why?
|
| Female | 135 | 2024 | 396233 | 0.320 |
Why?
|
| Positron-Emission Tomography | 7 | 2024 | 6545 | 0.310 |
Why?
|
| Inflammasomes | 2 | 2024 | 545 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2824 | 0.310 |
Why?
|
| Developmental Disabilities | 2 | 2017 | 1519 | 0.310 |
Why?
|
| Physical Chromosome Mapping | 2 | 2007 | 183 | 0.310 |
Why?
|
| Microtubule-Associated Proteins | 8 | 2021 | 1068 | 0.310 |
Why?
|
| Cysteine Endopeptidases | 4 | 2001 | 542 | 0.300 |
Why?
|
| Fibronectins | 3 | 2023 | 721 | 0.300 |
Why?
|
| Lipoylation | 2 | 2021 | 87 | 0.300 |
Why?
|
| Rats | 36 | 2024 | 23717 | 0.300 |
Why?
|
| Staurosporine | 5 | 2011 | 240 | 0.300 |
Why?
|
| Models, Genetic | 9 | 2024 | 3448 | 0.300 |
Why?
|
| Receptors, LDL | 3 | 2010 | 492 | 0.290 |
Why?
|
| Sterol O-Acyltransferase | 2 | 2005 | 28 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 14 | 8 | 2008 | 285 | 0.290 |
Why?
|
| Cell Line | 22 | 2024 | 15546 | 0.290 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2022 | 1884 | 0.290 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 1366 | 0.280 |
Why?
|
| Aprotinin | 3 | 2005 | 93 | 0.280 |
Why?
|
| Memory | 6 | 2020 | 2192 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 3 | 2011 | 1322 | 0.280 |
Why?
|
| Case-Control Studies | 22 | 2024 | 22228 | 0.280 |
Why?
|
| Lens, Crystalline | 4 | 2020 | 387 | 0.280 |
Why?
|
| Heart | 5 | 2020 | 4419 | 0.280 |
Why?
|
| alpha Catenin | 1 | 2007 | 37 | 0.280 |
Why?
|
| Genomics | 7 | 2024 | 5926 | 0.270 |
Why?
|
| Polymorphism, Restriction Fragment Length | 22 | 2010 | 765 | 0.270 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 130 | 0.270 |
Why?
|
| Meditation | 3 | 2020 | 256 | 0.270 |
Why?
|
| Protein Isoforms | 5 | 2022 | 1716 | 0.270 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 1426 | 0.260 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 365 | 0.260 |
Why?
|
| Calcium | 8 | 2010 | 5770 | 0.260 |
Why?
|
| Plant Extracts | 2 | 2021 | 496 | 0.260 |
Why?
|
| Homeostasis | 5 | 2012 | 3338 | 0.260 |
Why?
|
| Animals, Genetically Modified | 6 | 2020 | 1563 | 0.260 |
Why?
|
| Genome, Human | 7 | 2016 | 4443 | 0.260 |
Why?
|
| Cell Differentiation | 7 | 2020 | 11642 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 10 | 2015 | 3751 | 0.250 |
Why?
|
| Peptides | 5 | 2019 | 4338 | 0.250 |
Why?
|
| Exercise | 2 | 2022 | 5939 | 0.250 |
Why?
|
| Lod Score | 14 | 2007 | 600 | 0.250 |
Why?
|
| Protein Folding | 2 | 2010 | 868 | 0.250 |
Why?
|
| 3' Untranslated Regions | 2 | 2005 | 514 | 0.250 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 2045 | 0.240 |
Why?
|
| RNA, Small Interfering | 8 | 2015 | 3424 | 0.240 |
Why?
|
| Molecular Sequence Data | 33 | 2010 | 17597 | 0.240 |
Why?
|
| Interleukin-6 | 5 | 2021 | 3227 | 0.240 |
Why?
|
| Models, Neurological | 3 | 2015 | 1746 | 0.240 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2005 | 118 | 0.240 |
Why?
|
| Molecular Epidemiology | 2 | 2005 | 472 | 0.240 |
Why?
|
| Yoga | 2 | 2020 | 277 | 0.230 |
Why?
|
| Cataract | 5 | 2022 | 837 | 0.230 |
Why?
|
| Endocytosis | 6 | 2011 | 952 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2017 | 2743 | 0.230 |
Why?
|
| Coculture Techniques | 3 | 2024 | 1336 | 0.230 |
Why?
|
| Genetic Testing | 10 | 2019 | 3594 | 0.230 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 642 | 0.230 |
Why?
|
| Transcription Factors | 5 | 2022 | 12130 | 0.230 |
Why?
|
| Microscopy, Confocal | 4 | 2024 | 1967 | 0.230 |
Why?
|
| Cat's Claw | 2 | 2021 | 2 | 0.230 |
Why?
|
| Models, Biological | 12 | 2024 | 9445 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 9 | 6 | 2009 | 533 | 0.230 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 11906 | 0.230 |
Why?
|
| Solubility | 6 | 2016 | 1077 | 0.230 |
Why?
|
| Oxidation-Reduction | 8 | 2020 | 2221 | 0.230 |
Why?
|
| Cathepsin D | 2 | 2001 | 59 | 0.230 |
Why?
|
| Health Promotion | 1 | 2016 | 2209 | 0.230 |
Why?
|
| Hypocapnia | 1 | 2004 | 38 | 0.220 |
Why?
|
| Fibroblasts | 8 | 2024 | 4162 | 0.220 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2023 | 778 | 0.220 |
Why?
|
| Middle Aged | 72 | 2024 | 223083 | 0.220 |
Why?
|
| Neprilysin | 2 | 2023 | 484 | 0.220 |
Why?
|
| Crystallins | 2 | 2020 | 75 | 0.220 |
Why?
|
| Receptors, sigma | 1 | 2024 | 46 | 0.220 |
Why?
|
| Drug Design | 3 | 2020 | 1040 | 0.220 |
Why?
|
| Risk Factors | 29 | 2024 | 74857 | 0.220 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2024 | 88 | 0.220 |
Why?
|
| Protein Binding | 15 | 2020 | 9301 | 0.220 |
Why?
|
| Exons | 9 | 2021 | 2393 | 0.220 |
Why?
|
| Synapses | 4 | 2016 | 1759 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2021 | 14456 | 0.220 |
Why?
|
| Blood-Brain Barrier | 3 | 2024 | 1036 | 0.210 |
Why?
|
| Genome | 3 | 2023 | 1753 | 0.210 |
Why?
|
| Tauopathies | 2 | 2024 | 325 | 0.210 |
Why?
|
| Subcellular Fractions | 7 | 2016 | 528 | 0.210 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10433 | 0.210 |
Why?
|
| Aged, 80 and over | 40 | 2024 | 59515 | 0.210 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 3 | 2011 | 24 | 0.200 |
Why?
|
| Dura Mater | 1 | 2024 | 292 | 0.200 |
Why?
|
| Cell Death | 5 | 2018 | 1676 | 0.200 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2022 | 22 | 0.200 |
Why?
|
| Roseolovirus Infections | 2 | 2020 | 50 | 0.200 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 74 | 0.200 |
Why?
|
| Genetic Heterogeneity | 4 | 2020 | 735 | 0.200 |
Why?
|
| Tomography, Optical Coherence | 4 | 2018 | 2877 | 0.190 |
Why?
|
| Inclusion Bodies | 3 | 2010 | 277 | 0.190 |
Why?
|
| Immunity | 2 | 2019 | 1001 | 0.190 |
Why?
|
| Phosphorylation | 13 | 2021 | 8292 | 0.190 |
Why?
|
| Graphite | 1 | 2022 | 77 | 0.190 |
Why?
|
| Chemotaxis | 1 | 2024 | 596 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 694 | 0.190 |
Why?
|
| Peroxidase | 1 | 2024 | 610 | 0.190 |
Why?
|
| Haplotypes | 9 | 2019 | 2726 | 0.190 |
Why?
|
| Fluorine Radioisotopes | 1 | 2024 | 399 | 0.180 |
Why?
|
| Memory Disorders | 4 | 2023 | 1193 | 0.180 |
Why?
|
| Protein Kinase C-alpha | 2 | 2022 | 112 | 0.180 |
Why?
|
| Structure-Activity Relationship | 6 | 2021 | 3051 | 0.180 |
Why?
|
| Multienzyme Complexes | 3 | 2001 | 663 | 0.180 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 386 | 0.180 |
Why?
|
| Gliosis | 3 | 2020 | 247 | 0.180 |
Why?
|
| Up-Regulation | 6 | 2020 | 4133 | 0.180 |
Why?
|
| Recombination, Genetic | 8 | 1994 | 1525 | 0.180 |
Why?
|
| Amino Acid Substitution | 6 | 2011 | 1742 | 0.180 |
Why?
|
| Interleukin-1 | 3 | 2002 | 1242 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2271 | 0.170 |
Why?
|
| Macaca mulatta | 3 | 2023 | 2341 | 0.170 |
Why?
|
| Roseolovirus | 1 | 2020 | 2 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 3 | 2000 | 1077 | 0.170 |
Why?
|
| Transcription, Genetic | 10 | 2019 | 7600 | 0.170 |
Why?
|
| Dystonic Disorders | 1 | 2024 | 354 | 0.170 |
Why?
|
| Interleukin-3 | 1 | 2021 | 423 | 0.170 |
Why?
|
| Metalloproteases | 1 | 2020 | 61 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2007 | 350 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 519 | 0.170 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 20 | 0.170 |
Why?
|
| Chromosomes, Human | 4 | 2004 | 437 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 247 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2000 | 2849 | 0.170 |
Why?
|
| Hydrogen Peroxide | 7 | 2004 | 740 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 3 | 1994 | 73 | 0.160 |
Why?
|
| Encephalitis | 1 | 2023 | 440 | 0.160 |
Why?
|
| Cytoplasm | 4 | 2017 | 1498 | 0.160 |
Why?
|
| Thiazoles | 3 | 2016 | 1528 | 0.160 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.160 |
Why?
|
| Malacoplakia | 1 | 1999 | 15 | 0.160 |
Why?
|
| Proanthocyanidins | 1 | 2019 | 20 | 0.160 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 3818 | 0.160 |
Why?
|
| Glucosyltransferases | 1 | 2019 | 94 | 0.160 |
Why?
|
| Periapical Periodontitis | 1 | 1999 | 28 | 0.160 |
Why?
|
| Macaca fascicularis | 2 | 2021 | 908 | 0.160 |
Why?
|
| Learning | 2 | 2023 | 1755 | 0.160 |
Why?
|
| Amyloidogenic Proteins | 3 | 2024 | 152 | 0.160 |
Why?
|
| Interleukin-12 | 1 | 2021 | 581 | 0.150 |
Why?
|
| Gene Regulatory Networks | 4 | 2024 | 1750 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 2068 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2001 | 334 | 0.150 |
Why?
|
| Chemokines | 2 | 2021 | 959 | 0.150 |
Why?
|
| 5' Untranslated Regions | 3 | 2007 | 255 | 0.150 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 287 | 0.150 |
Why?
|
| Disease Progression | 8 | 2023 | 13616 | 0.150 |
Why?
|
| Trinucleotide Repeats | 1 | 2019 | 257 | 0.150 |
Why?
|
| Neuropsychological Tests | 12 | 2018 | 7119 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2019 | 313 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2000 | 489 | 0.150 |
Why?
|
| Family Health | 5 | 2016 | 1253 | 0.150 |
Why?
|
| Neuromuscular Junction | 2 | 2019 | 399 | 0.150 |
Why?
|
| Encephalitis, Viral | 1 | 2018 | 59 | 0.150 |
Why?
|
| Elastin | 1 | 2019 | 298 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 14 | 2011 | 6102 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2144 | 0.150 |
Why?
|
| Inflammation Mediators | 3 | 2018 | 1890 | 0.150 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9527 | 0.150 |
Why?
|
| Recombinant Proteins | 12 | 2010 | 6493 | 0.150 |
Why?
|
| Herpesviridae | 1 | 2018 | 104 | 0.150 |
Why?
|
| Lysosomes | 2 | 2018 | 932 | 0.150 |
Why?
|
| Base Sequence | 27 | 2002 | 12405 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2020 | 575 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2008 | 340 | 0.140 |
Why?
|
| Neurofibrils | 1 | 1997 | 75 | 0.140 |
Why?
|
| Hormones | 1 | 2021 | 865 | 0.140 |
Why?
|
| Radiopharmaceuticals | 2 | 2024 | 2702 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 2136 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2023 | 1805 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2023 | 904 | 0.140 |
Why?
|
| Reference Values | 9 | 2013 | 4909 | 0.140 |
Why?
|
| Maze Learning | 4 | 2020 | 482 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.140 |
Why?
|
| Anesthetics, Intravenous | 2 | 2011 | 395 | 0.140 |
Why?
|
| Cytokines | 4 | 2021 | 7426 | 0.140 |
Why?
|
| Pyloric Antrum | 1 | 1997 | 66 | 0.140 |
Why?
|
| Amino Acid Sequence | 20 | 2017 | 13400 | 0.140 |
Why?
|
| NAD | 1 | 2021 | 618 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2024 | 415 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2021 | 10737 | 0.140 |
Why?
|
| Monocytes | 2 | 2024 | 2591 | 0.140 |
Why?
|
| Dendrites | 2 | 2019 | 469 | 0.140 |
Why?
|
| Neuralgia | 1 | 2023 | 627 | 0.140 |
Why?
|
| Carbazoles | 1 | 2018 | 229 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 4342 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9601 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2024 | 1065 | 0.130 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 885 | 0.130 |
Why?
|
| Coat Protein Complex I | 1 | 2016 | 37 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 776 | 0.130 |
Why?
|
| Inflammation | 6 | 2023 | 10860 | 0.130 |
Why?
|
| Cell Membrane | 6 | 2018 | 3635 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 699 | 0.130 |
Why?
|
| Huntington Disease | 13 | 1993 | 1147 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 544 | 0.130 |
Why?
|
| Heterozygote | 6 | 2023 | 2796 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2005 | 2114 | 0.130 |
Why?
|
| Ion Channels | 1 | 2021 | 1044 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2014 | 414 | 0.130 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 50 | 0.130 |
Why?
|
| Sialic Acids | 2 | 1986 | 119 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 7 | 2011 | 1318 | 0.130 |
Why?
|
| Protein Multimerization | 3 | 2016 | 959 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 8113 | 0.130 |
Why?
|
| Kinetics | 8 | 2023 | 6273 | 0.130 |
Why?
|
| Adult | 37 | 2024 | 223139 | 0.130 |
Why?
|
| Peptide Hydrolases | 3 | 2005 | 608 | 0.130 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.130 |
Why?
|
| Apolipoprotein E2 | 3 | 2007 | 133 | 0.130 |
Why?
|
| Drug Repositioning | 1 | 2018 | 245 | 0.120 |
Why?
|
| Chromosome Aberrations | 5 | 2008 | 1775 | 0.120 |
Why?
|
| Synaptotagmins | 1 | 2015 | 53 | 0.120 |
Why?
|
| Cathepsin L | 1 | 2015 | 69 | 0.120 |
Why?
|
| Energy Metabolism | 2 | 2022 | 2894 | 0.120 |
Why?
|
| Drug Combinations | 2 | 2020 | 2076 | 0.120 |
Why?
|
| Residential Treatment | 1 | 2016 | 112 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 6 | 2017 | 4780 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2022 | 1121 | 0.120 |
Why?
|
| Immunohistochemistry | 15 | 2015 | 11035 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2018 | 752 | 0.120 |
Why?
|
| Drug Approval | 2 | 2021 | 820 | 0.120 |
Why?
|
| Adenolymphoma | 2 | 1987 | 11 | 0.120 |
Why?
|
| Binding Sites | 7 | 2012 | 6001 | 0.120 |
Why?
|
| Delirium | 1 | 2006 | 1699 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1186 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2024 | 1980 | 0.120 |
Why?
|
| Mucins | 3 | 1988 | 568 | 0.120 |
Why?
|
| Insulin | 5 | 2018 | 6604 | 0.120 |
Why?
|
| Cadherins | 4 | 2010 | 900 | 0.120 |
Why?
|
| Brain Injuries | 2 | 2020 | 2062 | 0.120 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 800 | 0.110 |
Why?
|
| Transgenes | 1 | 2018 | 1014 | 0.110 |
Why?
|
| HEK293 Cells | 6 | 2024 | 4263 | 0.110 |
Why?
|
| Signal Transduction | 9 | 2024 | 23605 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1592 | 0.110 |
Why?
|
| Eye Proteins | 2 | 2015 | 628 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2022 | 1187 | 0.110 |
Why?
|
| Propofol | 2 | 2011 | 607 | 0.110 |
Why?
|
| Anesthesia, General | 2 | 2014 | 1187 | 0.110 |
Why?
|
| Benzene Derivatives | 1 | 2014 | 51 | 0.110 |
Why?
|
| Macrophages | 3 | 2019 | 5776 | 0.110 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 1993 | 18 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 1998 | 883 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2007 | 185 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2017 | 3946 | 0.110 |
Why?
|
| DNA | 23 | 2003 | 7193 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 1997 | 602 | 0.110 |
Why?
|
| Sequence Tagged Sites | 2 | 1994 | 96 | 0.110 |
Why?
|
| Myocardium | 3 | 2016 | 4766 | 0.110 |
Why?
|
| Electroporation | 2 | 2025 | 238 | 0.110 |
Why?
|
| DNA Mutational Analysis | 7 | 2012 | 4112 | 0.110 |
Why?
|
| Sex Factors | 5 | 2021 | 10614 | 0.110 |
Why?
|
| Selection Bias | 1 | 2015 | 359 | 0.110 |
Why?
|
| Awareness | 1 | 2017 | 653 | 0.110 |
Why?
|
| Cytosol | 3 | 2008 | 885 | 0.110 |
Why?
|
| Precipitin Tests | 5 | 2004 | 812 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2015 | 169 | 0.110 |
Why?
|
| Postoperative Complications | 4 | 2014 | 15808 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 3501 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 103 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2007 | 432 | 0.100 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2013 | 84 | 0.100 |
Why?
|
| Age Factors | 7 | 2018 | 18386 | 0.100 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.100 |
Why?
|
| Glioma | 10 | 2011 | 3491 | 0.100 |
Why?
|
| Infection Control | 1 | 2020 | 984 | 0.100 |
Why?
|
| Cohort Studies | 13 | 2024 | 41684 | 0.100 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2012 | 9 | 0.100 |
Why?
|
| Lipids | 2 | 2019 | 3316 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1673 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12529 | 0.100 |
Why?
|
| PC12 Cells | 5 | 2015 | 316 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2536 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 572 | 0.100 |
Why?
|
| SUMO-1 Protein | 1 | 2012 | 35 | 0.100 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 284 | 0.100 |
Why?
|
| Myofibrils | 1 | 2013 | 143 | 0.100 |
Why?
|
| Glaucoma | 1 | 2022 | 1194 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2020 | 1724 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 1677 | 0.100 |
Why?
|
| Tissue Distribution | 4 | 2024 | 2271 | 0.100 |
Why?
|
| Cell Movement | 1 | 2024 | 5196 | 0.100 |
Why?
|
| Chromosomes, Human, 4-5 | 3 | 1986 | 26 | 0.100 |
Why?
|
| COS Cells | 4 | 2016 | 1135 | 0.100 |
Why?
|
| Phenotype | 9 | 2021 | 16716 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 487 | 0.100 |
Why?
|
| Cosmids | 2 | 1993 | 105 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 713 | 0.100 |
Why?
|
| Brain Injury, Chronic | 1 | 2012 | 68 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2015 | 412 | 0.100 |
Why?
|
| Membrane Transport Proteins | 2 | 2024 | 1029 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 118 | 0.100 |
Why?
|
| Cloning, Molecular | 13 | 1996 | 4163 | 0.100 |
Why?
|
| Empathy | 1 | 2016 | 474 | 0.100 |
Why?
|
| Proteins | 2 | 2021 | 5995 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3586 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 1986 | 521 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2015 | 743 | 0.090 |
Why?
|
| Repressor Proteins | 3 | 2000 | 2974 | 0.090 |
Why?
|
| Hybrid Cells | 8 | 1994 | 420 | 0.090 |
Why?
|
| Alternative Splicing | 3 | 2010 | 1103 | 0.090 |
Why?
|
| Cerebral Cortex | 7 | 2020 | 5758 | 0.090 |
Why?
|
| Protease Inhibitors | 3 | 2000 | 750 | 0.090 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3733 | 0.090 |
Why?
|
| Iron | 7 | 2010 | 1811 | 0.090 |
Why?
|
| Receptors, Opioid, delta | 1 | 2011 | 48 | 0.090 |
Why?
|
| Galectin 3 | 2 | 2023 | 238 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 1993 | 325 | 0.090 |
Why?
|
| Preoperative Period | 1 | 2013 | 565 | 0.090 |
Why?
|
| Oligopeptides | 4 | 2008 | 1195 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 516 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2022 | 3988 | 0.090 |
Why?
|
| Autophagy | 1 | 2019 | 1349 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2000 | 839 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 3 | 2010 | 871 | 0.090 |
Why?
|
| Caenorhabditis elegans | 4 | 2016 | 1476 | 0.090 |
Why?
|
| Temporal Lobe | 3 | 2013 | 1715 | 0.090 |
Why?
|
| Ceruloplasmin | 1 | 2010 | 57 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1039 | 0.090 |
Why?
|
| Air Pollution | 1 | 2024 | 2380 | 0.090 |
Why?
|
| Receptors, Complement | 1 | 2011 | 240 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 8038 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2007 | 1056 | 0.090 |
Why?
|
| Life Style | 1 | 2022 | 3928 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2015 | 749 | 0.080 |
Why?
|
| Ionophores | 1 | 2010 | 108 | 0.080 |
Why?
|
| Amino Acid Motifs | 3 | 2012 | 924 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2010 | 124 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 1998 | 2864 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2017 | 1343 | 0.080 |
Why?
|
| Longevity | 1 | 1997 | 1085 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1989 | 103 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 280 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 3 | 2006 | 2627 | 0.080 |
Why?
|
| Pyridines | 2 | 2020 | 2889 | 0.080 |
Why?
|
| Catalysis | 3 | 2007 | 767 | 0.080 |
Why?
|
| Hexanones | 1 | 2008 | 5 | 0.080 |
Why?
|
| Risk | 2 | 2020 | 9599 | 0.080 |
Why?
|
| Heat-Shock Proteins | 3 | 2008 | 790 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 2815 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2015 | 961 | 0.080 |
Why?
|
| Etoposide | 2 | 2003 | 636 | 0.080 |
Why?
|
| Imidazoles | 2 | 2014 | 1169 | 0.080 |
Why?
|
| Species Specificity | 3 | 2015 | 2406 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2023 | 713 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3796 | 0.080 |
Why?
|
| Cholesterol | 3 | 2003 | 2902 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2007 | 24276 | 0.080 |
Why?
|
| Algorithms | 4 | 2022 | 14066 | 0.080 |
Why?
|
| Hydroxyquinolines | 1 | 2008 | 17 | 0.080 |
Why?
|
| Histocytochemistry | 4 | 1999 | 695 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 69 | 0.080 |
Why?
|
| Tunicamycin | 1 | 2008 | 108 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2022 | 1688 | 0.080 |
Why?
|
| Herpesvirus 6, Human | 2 | 2020 | 96 | 0.080 |
Why?
|
| Blast Injuries | 1 | 2012 | 318 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 3 | 2023 | 376 | 0.080 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1867 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1447 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2024 | 3787 | 0.080 |
Why?
|
| Cattle | 3 | 2015 | 3801 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2010 | 250 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3427 | 0.070 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 349 | 0.070 |
Why?
|
| Longitudinal Studies | 8 | 2024 | 14747 | 0.070 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2008 | 120 | 0.070 |
Why?
|
| Blood Platelets | 1 | 1998 | 2464 | 0.070 |
Why?
|
| Autistic Disorder | 2 | 2008 | 1238 | 0.070 |
Why?
|
| Methyl Ethers | 1 | 2009 | 196 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2646 | 0.070 |
Why?
|
| Chromosome Deletion | 4 | 2008 | 1384 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2010 | 2161 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2005 | 520 | 0.070 |
Why?
|
| Tubulin | 3 | 2023 | 694 | 0.070 |
Why?
|
| Ganglioglioma | 1 | 2007 | 36 | 0.070 |
Why?
|
| Antibodies | 3 | 2023 | 2415 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2005 | 1644 | 0.070 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2007 | 30 | 0.070 |
Why?
|
| Memantine | 1 | 2008 | 110 | 0.070 |
Why?
|
| Extracellular Space | 2 | 2014 | 563 | 0.070 |
Why?
|
| Time Factors | 10 | 2011 | 40108 | 0.070 |
Why?
|
| Apolipoprotein E3 | 2 | 1999 | 104 | 0.070 |
Why?
|
| Macromolecular Substances | 4 | 2010 | 1430 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7474 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1667 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 10 | 1991 | 1305 | 0.070 |
Why?
|
| Linear Models | 4 | 2013 | 5873 | 0.070 |
Why?
|
| Cell Survival | 4 | 2015 | 5747 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3247 | 0.070 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2008 | 209 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2021 | 1881 | 0.070 |
Why?
|
| Endosomes | 3 | 2023 | 521 | 0.070 |
Why?
|
| Computer Simulation | 6 | 2023 | 6254 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2004 | 2476 | 0.070 |
Why?
|
| Parkinson Disease | 3 | 2012 | 2885 | 0.070 |
Why?
|
| Amyloid Neuropathies | 1 | 2006 | 14 | 0.070 |
Why?
|
| Rectal Neoplasms | 2 | 1985 | 1183 | 0.070 |
Why?
|
| Cervix Mucus | 1 | 1986 | 18 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 184 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2010 | 361 | 0.060 |
Why?
|
| Neurites | 3 | 2014 | 389 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2012 | 782 | 0.060 |
Why?
|
| Dogs | 3 | 2007 | 3824 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2005 | 640 | 0.060 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 4 | 1985 | 45 | 0.060 |
Why?
|
| Computational Biology | 1 | 2018 | 3565 | 0.060 |
Why?
|
| Helminth Proteins | 2 | 1998 | 173 | 0.060 |
Why?
|
| Cystadenoma | 1 | 1986 | 76 | 0.060 |
Why?
|
| Nitrous Oxide | 1 | 2006 | 166 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 5695 | 0.060 |
Why?
|
| Autopsy | 2 | 2024 | 1011 | 0.060 |
Why?
|
| Uterine Cervical Diseases | 1 | 1986 | 75 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 656 | 0.060 |
Why?
|
| Nuclear Family | 3 | 2000 | 311 | 0.060 |
Why?
|
| Autoradiography | 2 | 2024 | 723 | 0.060 |
Why?
|
| Dimerization | 3 | 2006 | 881 | 0.060 |
Why?
|
| Colonic Neoplasms | 3 | 1988 | 2532 | 0.060 |
Why?
|
| Veins | 1 | 1989 | 769 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2010 | 2174 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2021 | 2667 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2024 | 565 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 1993 | 378 | 0.060 |
Why?
|
| Staining and Labeling | 5 | 1996 | 1072 | 0.060 |
Why?
|
| Acetylcysteine | 2 | 2008 | 262 | 0.060 |
Why?
|
| Neuroblastoma | 6 | 2021 | 1263 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2005 | 240 | 0.060 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 874 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1028 | 0.060 |
Why?
|
| Adenoma | 2 | 1986 | 2155 | 0.060 |
Why?
|
| Pulmonary Alveoli | 2 | 1979 | 665 | 0.060 |
Why?
|
| Receptors, Oxidized LDL | 1 | 2004 | 2 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1729 | 0.060 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2004 | 8 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2006 | 259 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 5 | 2001 | 1695 | 0.060 |
Why?
|
| DNA, Recombinant | 8 | 1996 | 455 | 0.060 |
Why?
|
| Apolipoprotein C-I | 1 | 2024 | 14 | 0.060 |
Why?
|
| Sweden | 3 | 2015 | 1381 | 0.060 |
Why?
|
| Halogenation | 1 | 2024 | 46 | 0.060 |
Why?
|
| Lymphatic System | 1 | 1986 | 250 | 0.060 |
Why?
|
| In Situ Hybridization | 7 | 1998 | 1885 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 361 | 0.060 |
Why?
|
| beta Catenin | 2 | 2000 | 1047 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 9 | 2003 | 6059 | 0.060 |
Why?
|
| Oligonucleotide Probes | 3 | 1996 | 416 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 844 | 0.060 |
Why?
|
| Polyamines | 1 | 2024 | 132 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2024 | 6840 | 0.050 |
Why?
|
| Edetic Acid | 2 | 1994 | 274 | 0.050 |
Why?
|
| Point Mutation | 3 | 1999 | 1591 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 1987 | 514 | 0.050 |
Why?
|
| Diazomethane | 1 | 2023 | 38 | 0.050 |
Why?
|
| Urologic Diseases | 1 | 1986 | 245 | 0.050 |
Why?
|
| Trypsin Inhibitors | 3 | 2001 | 32 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 8924 | 0.050 |
Why?
|
| Cytoskeleton | 2 | 2023 | 1179 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 160 | 0.050 |
Why?
|
| Receptors, CCR2 | 1 | 2024 | 215 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 109 | 0.050 |
Why?
|
| Hydrocarbons, Halogenated | 2 | 2015 | 21 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 1986 | 314 | 0.050 |
Why?
|
| DNA Probes | 4 | 1992 | 541 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 2 | 2001 | 88 | 0.050 |
Why?
|
| Emulsions | 1 | 2023 | 150 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2024 | 543 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2024 | 417 | 0.050 |
Why?
|
| Body Patterning | 1 | 2007 | 633 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 1331 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 319 | 0.050 |
Why?
|
| Organic Chemicals | 1 | 1984 | 211 | 0.050 |
Why?
|
| Microscopy | 2 | 2020 | 900 | 0.050 |
Why?
|
| Urinary Tract | 1 | 1986 | 305 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2013 | 1414 | 0.050 |
Why?
|
| Military Personnel | 1 | 2012 | 1260 | 0.050 |
Why?
|
| Pain | 1 | 2018 | 5090 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1378 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2011 | 4025 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1984 | 293 | 0.050 |
Why?
|
| Oxidative Stress | 5 | 2010 | 3140 | 0.050 |
Why?
|
| Aqueous Humor | 1 | 2003 | 152 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1931 | 0.050 |
Why?
|
| Multigene Family | 3 | 2011 | 1081 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3111 | 0.050 |
Why?
|
| Logistic Models | 4 | 2016 | 13273 | 0.050 |
Why?
|
| Leupeptins | 2 | 2015 | 112 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2000 | 39 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 511 | 0.050 |
Why?
|
| alpha-Synuclein | 2 | 2007 | 771 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3233 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 610 | 0.050 |
Why?
|
| Stroke | 1 | 2024 | 9748 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4863 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2020 | 2390 | 0.050 |
Why?
|
| Acyltransferases | 2 | 1994 | 305 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2015 | 411 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 2 | 2018 | 239 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1027 | 0.050 |
Why?
|
| Butyrates | 2 | 2015 | 164 | 0.050 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 2 | 1992 | 11 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2024 | 602 | 0.050 |
Why?
|
| Mental Health | 1 | 2016 | 3273 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2006 | 1754 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5382 | 0.050 |
Why?
|
| Pericytes | 1 | 2024 | 299 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 566 | 0.050 |
Why?
|
| Neurogranin | 1 | 2021 | 15 | 0.050 |
Why?
|
| Mathematics | 2 | 1997 | 696 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 975 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2024 | 54812 | 0.050 |
Why?
|
| Butyrylcholinesterase | 1 | 2000 | 21 | 0.050 |
Why?
|
| Anxiety | 1 | 2016 | 4672 | 0.050 |
Why?
|
| ROC Curve | 2 | 2024 | 3614 | 0.050 |
Why?
|
| Postural Balance | 2 | 2020 | 637 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2020 | 12426 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6208 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2003 | 575 | 0.050 |
Why?
|
| Laminin | 2 | 2015 | 404 | 0.050 |
Why?
|
| Response Elements | 1 | 2002 | 307 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 890 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4527 | 0.040 |
Why?
|
| Lymphocytes | 3 | 2007 | 2602 | 0.040 |
Why?
|
| 3-Hydroxyanthranilic Acid | 1 | 2000 | 8 | 0.040 |
Why?
|
| Paternal Age | 2 | 1992 | 87 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2677 | 0.040 |
Why?
|
| Gene Products, tat | 1 | 2000 | 111 | 0.040 |
Why?
|
| Nondisjunction, Genetic | 2 | 1992 | 24 | 0.040 |
Why?
|
| Chromatography, Gel | 3 | 1997 | 631 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2016 | 8532 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2015 | 3606 | 0.040 |
Why?
|
| Sphingomyelins | 2 | 2016 | 103 | 0.040 |
Why?
|
| Schizophrenia | 2 | 2010 | 6975 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2008 | 2353 | 0.040 |
Why?
|
| Phototherapy | 1 | 2023 | 369 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2024 | 589 | 0.040 |
Why?
|
| Entorhinal Cortex | 1 | 2002 | 285 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 11 | 1987 | 548 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 5 | 2008 | 5784 | 0.040 |
Why?
|
| Organ Specificity | 3 | 1994 | 1966 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2718 | 0.040 |
Why?
|
| Random Allocation | 2 | 2017 | 2395 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1986 | 1113 | 0.040 |
Why?
|
| Light | 2 | 2020 | 1358 | 0.040 |
Why?
|
| Blotting, Northern | 7 | 2002 | 1546 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 250 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 154 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3458 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4044 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2000 | 49 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 1140 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1999 | 65 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2023 | 947 | 0.040 |
Why?
|
| Kynurenine | 1 | 2000 | 142 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 165 | 0.040 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 651 | 0.040 |
Why?
|
| Interneurons | 1 | 2024 | 593 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1999 | 289 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 1999 | 173 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 418 | 0.040 |
Why?
|
| Amnesia | 1 | 2001 | 257 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 1206 | 0.040 |
Why?
|
| Centrifugation | 1 | 1999 | 121 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2000 | 185 | 0.040 |
Why?
|
| Genes, Dominant | 4 | 1991 | 855 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 1987 | 3456 | 0.040 |
Why?
|
| United States | 6 | 2021 | 72920 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1986 | 949 | 0.040 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 335 | 0.040 |
Why?
|
| Cell Compartmentation | 2 | 1996 | 383 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2020 | 487 | 0.040 |
Why?
|
| Time | 1 | 2020 | 549 | 0.040 |
Why?
|
| Long-Term Potentiation | 2 | 2012 | 290 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 683 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 36548 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2001 | 374 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
| Filtration | 1 | 1999 | 227 | 0.040 |
Why?
|
| Bradycardia | 1 | 2020 | 304 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 2091 | 0.040 |
Why?
|
| Triglycerides | 1 | 2006 | 2441 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 2844 | 0.040 |
Why?
|
| Iohexol | 1 | 1999 | 205 | 0.040 |
Why?
|
| Veterans | 1 | 2012 | 2667 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 7 | 2001 | 9237 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2018 | 1524 | 0.040 |
Why?
|
| Ubiquitination | 2 | 2015 | 1000 | 0.040 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1982 | 306 | 0.040 |
Why?
|
| Biological Phenomena | 1 | 2018 | 27 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 2 | 2010 | 423 | 0.040 |
Why?
|
| Thalamus | 1 | 2024 | 1040 | 0.040 |
Why?
|
| Metals, Heavy | 1 | 1999 | 149 | 0.040 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2018 | 65 | 0.040 |
Why?
|
| Maternal Age | 2 | 1992 | 804 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 428 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1119 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1490 | 0.040 |
Why?
|
| Pseudogenes | 2 | 1994 | 104 | 0.040 |
Why?
|
| Octoxynol | 1 | 1997 | 76 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1885 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 75 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 106 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2020 | 840 | 0.040 |
Why?
|
| Isoleucine | 2 | 1998 | 111 | 0.030 |
Why?
|
| Intestines | 1 | 1986 | 1904 | 0.030 |
Why?
|
| Hydrogels | 1 | 2023 | 729 | 0.030 |
Why?
|
| Primates | 1 | 2020 | 519 | 0.030 |
Why?
|
| Finland | 2 | 2009 | 608 | 0.030 |
Why?
|
| Brazil | 1 | 2021 | 1248 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2009 | 361 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 1997 | 68 | 0.030 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 593 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 367 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15882 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 651 | 0.030 |
Why?
|
| Holidays | 1 | 2016 | 41 | 0.030 |
Why?
|
| Retina | 1 | 2007 | 2646 | 0.030 |
Why?
|
| Estradiol | 1 | 2024 | 1947 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 268 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2008 | 820 | 0.030 |
Why?
|
| Massage | 1 | 2016 | 84 | 0.030 |
Why?
|
| Biopolymers | 1 | 1997 | 181 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.030 |
Why?
|
| Epithelium | 4 | 1988 | 1604 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1241 | 0.030 |
Why?
|
| Acidosis | 1 | 1998 | 271 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2016 | 165 | 0.030 |
Why?
|
| Pupa | 1 | 2015 | 42 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2024 | 3159 | 0.030 |
Why?
|
| Piperidines | 1 | 2024 | 1664 | 0.030 |
Why?
|
| Cell Size | 1 | 2018 | 626 | 0.030 |
Why?
|
| Upstream Stimulatory Factors | 1 | 1995 | 17 | 0.030 |
Why?
|
| Titrimetry | 1 | 2015 | 36 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Receptors, Notch | 3 | 2010 | 751 | 0.030 |
Why?
|
| Synaptotagmin II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Coloring Agents | 2 | 2011 | 563 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1997 | 365 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2012 | 1213 | 0.030 |
Why?
|
| Lens Diseases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Synaptotagmin I | 1 | 2015 | 33 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 916 | 0.030 |
Why?
|
| Restriction Mapping | 3 | 1993 | 848 | 0.030 |
Why?
|
| Feedback | 1 | 1999 | 796 | 0.030 |
Why?
|
| Software | 3 | 2018 | 4463 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1976 | 106 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 721 | 0.030 |
Why?
|
| Valine | 2 | 1998 | 410 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 858 | 0.030 |
Why?
|
| Prevalence | 2 | 2018 | 15827 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 2 | 1985 | 55 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 645 | 0.030 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2015 | 38 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 2015 | 138 | 0.030 |
Why?
|
| Dopamine | 1 | 2002 | 1582 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2868 | 0.030 |
Why?
|
| Geriatrics | 1 | 1999 | 394 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 1503 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 403 | 0.030 |
Why?
|
| Anesthesia | 1 | 2006 | 1595 | 0.030 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2015 | 89 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1205 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 2016 | 181 | 0.030 |
Why?
|
| Kaolin | 1 | 1994 | 16 | 0.030 |
Why?
|
| Biodiversity | 1 | 2017 | 344 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1995 | 287 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2015 | 241 | 0.030 |
Why?
|
| Calpain | 1 | 2015 | 146 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2024 | 1857 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 871 | 0.030 |
Why?
|
| Translocation, Genetic | 3 | 1989 | 1393 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2015 | 245 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 1976 | 1985 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 368 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2007 | 107 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 1084 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2024 | 2224 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 1994 | 228 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3002 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 348 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 2002 | 900 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2415 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2006 | 9065 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 473 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1513 | 0.030 |
Why?
|
| Sample Size | 1 | 1997 | 843 | 0.030 |
Why?
|
| Metagenome | 1 | 2017 | 464 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 187 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2838 | 0.030 |
Why?
|
| Quantum Dots | 1 | 2015 | 166 | 0.030 |
Why?
|
| Genes, fos | 1 | 1993 | 176 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1993 | 191 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 1043 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2015 | 694 | 0.030 |
Why?
|
| Wilms Tumor | 1 | 1976 | 378 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 12235 | 0.030 |
Why?
|
| Health Behavior | 1 | 2024 | 2649 | 0.030 |
Why?
|
| Internet | 2 | 2018 | 3107 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 4556 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 1975 | 353 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 582 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 915 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 743 | 0.030 |
Why?
|
| International Cooperation | 2 | 2010 | 1433 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 328 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4565 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 965 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2062 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2012 | 119 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 1150 | 0.020 |
Why?
|
| Adolescent | 7 | 2020 | 88819 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 1992 | 92 | 0.020 |
Why?
|
| Alanine | 1 | 2014 | 613 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 2011 | 34 | 0.020 |
Why?
|
| Propidium | 1 | 2011 | 42 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1994 | 625 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 676 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2017 | 702 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1987 | 4049 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2011 | 53 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2016 | 870 | 0.020 |
Why?
|
| Chromosome Disorders | 3 | 1989 | 498 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 619 | 0.020 |
Why?
|
| Photons | 1 | 2015 | 571 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2019 | 1811 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65219 | 0.020 |
Why?
|
| Acceleration | 1 | 2012 | 189 | 0.020 |
Why?
|
| DNA, Complementary | 3 | 2005 | 1984 | 0.020 |
Why?
|
| Blotting, Southern | 4 | 1994 | 772 | 0.020 |
Why?
|
| Centromere | 1 | 1992 | 214 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 1790 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3431 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2023 | 3068 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2018 | 1148 | 0.020 |
Why?
|
| Proteomics | 1 | 2024 | 3907 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2006 | 4544 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1198 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 261 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 351 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2012 | 169 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1896 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1893 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 462 | 0.020 |
Why?
|
| Glutamates | 1 | 2011 | 384 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 259 | 0.020 |
Why?
|
| Phenanthrolines | 2 | 2000 | 48 | 0.020 |
Why?
|
| Xanthenes | 1 | 2010 | 71 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2020 | 1516 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1834 | 0.020 |
Why?
|
| Homozygote | 2 | 2012 | 1774 | 0.020 |
Why?
|
| Biological Transport | 3 | 2000 | 2080 | 0.020 |
Why?
|
| Cathelicidins | 1 | 2010 | 81 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 323 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 283 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 59868 | 0.020 |
Why?
|
| Desmin | 1 | 1989 | 99 | 0.020 |
Why?
|
| Ribosomes | 1 | 1993 | 495 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1989 | 6961 | 0.020 |
Why?
|
| Motor Activity | 1 | 2020 | 2711 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5986 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 193 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 889 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 2004 | 687 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 451 | 0.020 |
Why?
|
| Atrophy | 2 | 2008 | 1629 | 0.020 |
Why?
|
| Synucleins | 2 | 2001 | 108 | 0.020 |
Why?
|
| Body Water | 1 | 2010 | 337 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 945 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 386 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1405 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 576 | 0.020 |
Why?
|
| Vimentin | 1 | 1989 | 257 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1986 | 4904 | 0.020 |
Why?
|
| Chromatin | 1 | 2020 | 2981 | 0.020 |
Why?
|
| Monosomy | 1 | 1988 | 52 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1999 | 9354 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 1987 | 2890 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 505 | 0.020 |
Why?
|
| Heart Rate | 1 | 2020 | 4204 | 0.020 |
Why?
|
| Anesthesia, Spinal | 1 | 2011 | 280 | 0.020 |
Why?
|
| Superoxides | 2 | 2000 | 382 | 0.020 |
Why?
|
| Germany | 1 | 2011 | 882 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2017 | 9657 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4247 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2010 | 482 | 0.020 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 1988 | 27 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 1527 | 0.020 |
Why?
|
| Pilot Projects | 3 | 2011 | 8724 | 0.020 |
Why?
|
| Cerebellum | 2 | 1997 | 1519 | 0.020 |
Why?
|
| Purines | 2 | 2008 | 616 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 81565 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 202 | 0.020 |
Why?
|
| Pancreas | 1 | 1975 | 1699 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 272 | 0.020 |
Why?
|
| Liver | 1 | 1984 | 7559 | 0.020 |
Why?
|
| Oncogenes | 3 | 1988 | 1232 | 0.020 |
Why?
|
| Tyrosine | 2 | 2004 | 1427 | 0.020 |
Why?
|
| Oxazines | 1 | 2010 | 358 | 0.020 |
Why?
|
| Abdomen | 1 | 2014 | 1135 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1154 | 0.020 |
Why?
|
| RNA | 3 | 2012 | 2716 | 0.020 |
Why?
|
| Weight Gain | 1 | 2018 | 2356 | 0.020 |
Why?
|
| Lectins | 1 | 1989 | 487 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1989 | 447 | 0.020 |
Why?
|
| Hand Strength | 1 | 2010 | 464 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1928 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1988 | 386 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 2001 | 1769 | 0.020 |
Why?
|
| Space Perception | 1 | 2010 | 469 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 377 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2008 | 449 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 956 | 0.020 |
Why?
|
| MNSs Blood-Group System | 1 | 1986 | 7 | 0.020 |
Why?
|
| Benzazepines | 1 | 2008 | 308 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1988 | 174 | 0.020 |
Why?
|
| Carbamates | 1 | 2008 | 191 | 0.020 |
Why?
|
| Child, Preschool | 5 | 2020 | 42511 | 0.020 |
Why?
|
| Secretory Component | 1 | 1986 | 16 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3684 | 0.020 |
Why?
|
| Sialomucins | 1 | 1986 | 18 | 0.020 |
Why?
|
| Uterine Cervicitis | 1 | 1986 | 31 | 0.020 |
Why?
|
| Head | 1 | 2012 | 926 | 0.020 |
Why?
|
| Incidence | 1 | 2024 | 21513 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1987 | 417 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1260 | 0.020 |
Why?
|
| Intestine, Large | 1 | 1986 | 69 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 412 | 0.020 |
Why?
|
| Keratins | 1 | 1987 | 497 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 386 | 0.020 |
Why?
|
| Meiosis | 1 | 1988 | 326 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1175 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1986 | 139 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1997 | 5300 | 0.020 |
Why?
|
| Actins | 2 | 1991 | 2061 | 0.020 |
Why?
|
| Telomere | 1 | 1992 | 941 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1989 | 680 | 0.020 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 1986 | 158 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1638 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 2689 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 53 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1986 | 456 | 0.020 |
Why?
|
| Adenocarcinoma | 3 | 1989 | 6363 | 0.020 |
Why?
|
| China | 1 | 2011 | 2383 | 0.020 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1986 | 129 | 0.020 |
Why?
|
| RNA Probes | 2 | 1996 | 110 | 0.020 |
Why?
|
| Fear | 1 | 2014 | 1496 | 0.020 |
Why?
|
| Parotid Neoplasms | 1 | 1987 | 158 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2008 | 6324 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1987 | 731 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1986 | 313 | 0.010 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1986 | 133 | 0.010 |
Why?
|
| Depression | 1 | 2024 | 8230 | 0.010 |
Why?
|
| Carcinoma | 1 | 1976 | 2313 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1986 | 336 | 0.010 |
Why?
|
| Athletes | 1 | 2012 | 1162 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2351 | 0.010 |
Why?
|
| Trace Elements | 1 | 2006 | 193 | 0.010 |
Why?
|
| Chromosome Banding | 3 | 1988 | 261 | 0.010 |
Why?
|
| Fermentation | 1 | 1964 | 141 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26290 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 1001 | 0.010 |
Why?
|
| Child | 7 | 2020 | 80573 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1989 | 1143 | 0.010 |
Why?
|
| Polyps | 1 | 1986 | 200 | 0.010 |
Why?
|
| Chloroquine | 1 | 2005 | 276 | 0.010 |
Why?
|
| Leucine | 1 | 2005 | 547 | 0.010 |
Why?
|
| Environment | 1 | 2010 | 1119 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 771 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1964 | 261 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1971 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 828 | 0.010 |
Why?
|
| HIV-1 | 1 | 2000 | 6948 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1989 | 1494 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3274 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2795 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1987 | 575 | 0.010 |
Why?
|
| Prognosis | 3 | 2008 | 29912 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 931 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8882 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 1986 | 539 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 165 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 1836 | 0.010 |
Why?
|
| Boston | 2 | 2011 | 9335 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1986 | 992 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14645 | 0.010 |
Why?
|
| Deferoxamine | 1 | 2002 | 154 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 607 | 0.010 |
Why?
|
| Organelles | 1 | 2003 | 263 | 0.010 |
Why?
|
| Iron Chelating Agents | 1 | 2002 | 141 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1986 | 606 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 595 | 0.010 |
Why?
|
| Karyotyping | 3 | 1988 | 1175 | 0.010 |
Why?
|
| Collagen | 1 | 1989 | 2617 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2001 | 244 | 0.010 |
Why?
|
| Synaptophysin | 1 | 2001 | 137 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1883 | 0.010 |
Why?
|
| Mucin-1 | 1 | 1986 | 535 | 0.010 |
Why?
|
| Executive Function | 1 | 2010 | 1395 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2001 | 184 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1217 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2000 | 91 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1478 | 0.010 |
Why?
|
| Trientine | 1 | 2000 | 12 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1986 | 561 | 0.010 |
Why?
|
| Brain Concussion | 1 | 2012 | 1432 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 712 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 119 | 0.010 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 39 | 0.010 |
Why?
|
| Calcium Channels, N-Type | 1 | 2000 | 42 | 0.010 |
Why?
|
| Tetracycline | 1 | 2001 | 216 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1833 | 0.010 |
Why?
|
| Penicillamine | 1 | 2000 | 59 | 0.010 |
Why?
|
| Open Reading Frames | 2 | 1995 | 820 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2000 | 111 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1986 | 1739 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2000 | 142 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 2824 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8725 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1976 | 4352 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 1998 | 4809 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2010 | 2971 | 0.010 |
Why?
|
| Gangliosides | 1 | 2000 | 132 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1999 | 158 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13085 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1180 | 0.010 |
Why?
|
| Epitopes | 1 | 2006 | 2523 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1999 | 45 | 0.010 |
Why?
|
| Ethylenediamines | 1 | 1999 | 57 | 0.010 |
Why?
|
| Pyramidal Tracts | 2 | 1992 | 250 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1999 | 165 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1999 | 40 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2000 | 370 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 820 | 0.010 |
Why?
|
| Histidine | 1 | 2000 | 301 | 0.010 |
Why?
|
| Ion Transport | 1 | 2000 | 322 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 439 | 0.010 |
Why?
|
| Educational Status | 1 | 2007 | 2510 | 0.010 |
Why?
|
| Macaca | 1 | 2000 | 413 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 752 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1976 | 4282 | 0.010 |
Why?
|
| Selenomethionine | 2 | 1976 | 18 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 643 | 0.010 |
Why?
|
| Aldehydes | 1 | 2000 | 170 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2000 | 243 | 0.010 |
Why?
|
| Magnesium | 1 | 2002 | 815 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 578 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1998 | 55 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 780 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1979 | 193 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 237 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.010 |
Why?
|
| Neurocytoma | 1 | 1998 | 28 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 784 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 777 | 0.010 |
Why?
|
| Technetium | 2 | 1976 | 326 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1985 | 1424 | 0.010 |
Why?
|
| Parietal Lobe | 2 | 1995 | 859 | 0.010 |
Why?
|
| Tryptophan | 1 | 2000 | 483 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1986 | 2196 | 0.010 |
Why?
|
| Bradykinin | 1 | 1998 | 205 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 924 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 1748 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2001 | 1085 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1986 | 1996 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2000 | 550 | 0.010 |
Why?
|
| Diarrhea | 1 | 1964 | 1315 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 15403 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 4423 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2000 | 501 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 1999 | 367 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 1622 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2000 | 673 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 686 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1975 | 5454 | 0.010 |
Why?
|
| Glutamine | 1 | 2000 | 575 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3360 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2000 | 657 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 1425 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 6020 | 0.010 |
Why?
|
| Parathyroid Diseases | 1 | 1976 | 46 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 931 | 0.010 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2000 | 543 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20137 | 0.010 |
Why?
|
| Wales | 2 | 1986 | 87 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 420 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1099 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 1671 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2002 | 1363 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 327 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1994 | 112 | 0.010 |
Why?
|
| Chromatography | 1 | 1994 | 187 | 0.010 |
Why?
|
| Sepharose | 1 | 1994 | 100 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2000 | 1181 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1994 | 197 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10087 | 0.010 |
Why?
|
| Cadaver | 1 | 1998 | 1362 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1994 | 125 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 1710 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1988 | 5089 | 0.010 |
Why?
|
| Genomic Library | 1 | 1993 | 189 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1998 | 772 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1986 | 2040 | 0.010 |
Why?
|
| Glycosylation | 1 | 1996 | 1099 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1994 | 2077 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 828 | 0.010 |
Why?
|
| Fetus | 1 | 2000 | 1878 | 0.010 |
Why?
|
| Water | 1 | 1999 | 1416 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39243 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 8062 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1994 | 309 | 0.010 |
Why?
|
| Rodentia | 1 | 1994 | 263 | 0.010 |
Why?
|
| Rabbits | 1 | 1979 | 4730 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 180 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1976 | 2543 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 3637 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1994 | 392 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 1211 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1994 | 405 | 0.010 |
Why?
|
| North Carolina | 1 | 1993 | 329 | 0.010 |
Why?
|
| Venezuela | 1 | 1992 | 73 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1994 | 825 | 0.010 |
Why?
|
| Clone Cells | 1 | 1995 | 1671 | 0.010 |
Why?
|
| Computers | 2 | 1989 | 588 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 3616 | 0.010 |
Why?
|
| Plasmids | 2 | 1988 | 2267 | 0.010 |
Why?
|
| Gerbillinae | 1 | 1991 | 87 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1976 | 13483 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1159 | 0.010 |
Why?
|
| Gene Library | 1 | 1994 | 1066 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2001 | 12976 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1997 | 3073 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9082 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1997 | 1611 | 0.010 |
Why?
|
| Reperfusion | 1 | 1991 | 268 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 527 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 30233 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 1988 | 33 | 0.000 |
Why?
|
| RNA, Complementary | 1 | 1988 | 46 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1988 | 142 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6421 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1997 | 2445 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1994 | 1674 | 0.000 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1987 | 14 | 0.000 |
Why?
|
| Phosphofructokinase-1 | 1 | 1987 | 51 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1985 | 9378 | 0.000 |
Why?
|
| Trisomy | 1 | 1988 | 260 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 22344 | 0.000 |
Why?
|
| Biopsy | 1 | 1979 | 6768 | 0.000 |
Why?
|
| Ligases | 1 | 1988 | 330 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 5836 | 0.000 |
Why?
|
| Locus Coeruleus | 1 | 1988 | 241 | 0.000 |
Why?
|
| DNA, Ribosomal | 1 | 1987 | 300 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1989 | 573 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1991 | 1077 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 4887 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12061 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1987 | 564 | 0.000 |
Why?
|
| Aneuploidy | 1 | 1987 | 576 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1987 | 1616 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15647 | 0.000 |
Why?
|
| Ovary | 1 | 1985 | 961 | 0.000 |
Why?
|
| Health Surveys | 1 | 1989 | 4058 | 0.000 |
Why?
|
| Syndrome | 1 | 1985 | 3270 | 0.000 |
Why?
|
| Infant | 2 | 1976 | 36427 | 0.000 |
Why?
|
| Genetic Engineering | 1 | 1985 | 933 | 0.000 |
Why?
|
| Parathyroid Neoplasms | 1 | 1976 | 244 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1984 | 3400 | 0.000 |
Why?
|
| Parents | 1 | 1988 | 3591 | 0.000 |
Why?
|